These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33632650)

  • 1. The Benefits of Vaccinating With the First Available COVID-19 Coronavirus Vaccine.
    Bartsch SM; O'Shea KJ; Wedlock PT; Strych U; Ferguson MC; Bottazzi ME; Randall SL; Siegmund SS; Cox SN; Hotez PJ; Lee BY
    Am J Prev Med; 2021 May; 60(5):605-613. PubMed ID: 33632650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of vaccination on the COVID-19 pandemic in U.S. states.
    Chen X; Huang H; Ju J; Sun R; Zhang J
    Sci Rep; 2022 Jan; 12(1):1554. PubMed ID: 35091640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lives and Costs Saved by Expanding and Expediting Coronavirus Disease 2019 Vaccination.
    Bartsch SM; Wedlock PT; O'Shea KJ; Cox SN; Strych U; Nuzzo JB; Ferguson MC; Bottazzi ME; Siegmund SS; Hotez PJ; Lee BY
    J Infect Dis; 2021 Sep; 224(6):938-948. PubMed ID: 33954775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention.
    Bartsch SM; O'Shea KJ; Ferguson MC; Bottazzi ME; Wedlock PT; Strych U; McKinnell JA; Siegmund SS; Cox SN; Hotez PJ; Lee BY
    Am J Prev Med; 2020 Oct; 59(4):493-503. PubMed ID: 32778354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination - United States, September and December 2020.
    Nguyen KH; Srivastav A; Razzaghi H; Williams W; Lindley MC; Jorgensen C; Abad N; Singleton JA
    MMWR Morb Mortal Wkly Rep; 2021 Feb; 70(6):217-222. PubMed ID: 33571174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes Of A COVID-19 Vaccine: Implementation Over Efficacy.
    Paltiel AD; Schwartz JL; Zheng A; Walensky RP
    Health Aff (Millwood); 2021 Jan; 40(1):42-52. PubMed ID: 33211536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 - Important considerations for developing and using a vaccine.
    Rahman IU; Ali N; Ijaz F; Afzal A; Abd Allah EF
    Hum Vaccin Immunother; 2021 Feb; 17(2):414-415. PubMed ID: 32693665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
    Amanpour S
    Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of COVID-19 Vaccines in Preventing Hospitalization Among Adults Aged ≥65 Years - COVID-NET, 13 States, February-April 2021.
    Moline HL; Whitaker M; Deng L; Rhodes JC; Milucky J; Pham H; Patel K; Anglin O; Reingold A; Chai SJ; Alden NB; Kawasaki B; Meek J; Yousey-Hindes K; Anderson EJ; Farley MM; Ryan PA; Kim S; Nunez VT; Como-Sabetti K; Lynfield R; Sosin DM; McMullen C; Muse A; Barney G; Bennett NM; Bushey S; Shiltz J; Sutton M; Abdullah N; Talbot HK; Schaffner W; Chatelain R; Ortega J; Murthy BP; Zell E; Schrag SJ; Taylor C; Shang N; Verani JR; Havers FP
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1088-1093. PubMed ID: 34383730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving pandemic preparedness through better, faster influenza vaccines.
    Newland M; Durham D; Asher J; Treanor JJ; Seals J; Donis RO; Johnson RA
    Expert Rev Vaccines; 2021 Mar; 20(3):235-242. PubMed ID: 33576708
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.
    Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of vaccine prioritization strategies on mitigating COVID-19: an agent-based simulation study using an urban region in the United States.
    Tatapudi H; Das R; Das TK
    BMC Med Res Methodol; 2021 Dec; 21(1):272. PubMed ID: 34865617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The balancing role of distribution speed against varying efficacy levels of COVID-19 vaccines under variants.
    Kim D; Keskinocak P; Pekgün P; Yildirim İ
    Sci Rep; 2022 May; 12(1):7493. PubMed ID: 35523832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccines: Preparing for Vaccination in the Context of Clinical Oncology Care.
    Carr E
    Clin J Oncol Nurs; 2021 Feb; 25(1):76-84. PubMed ID: 33480870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Source of information on COVID-19 vaccine and vaccine hesitancy among U.S. Medicare beneficiaries.
    Kim J; Kim Y; Li Y
    J Am Geriatr Soc; 2022 Mar; 70(3):677-680. PubMed ID: 34894409
    [No Abstract]   [Full Text] [Related]  

  • 20. Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.
    Romero-Brufau S; Chopra A; Ryu AJ; Gel E; Raskar R; Kremers W; Anderson KS; Subramanian J; Krishnamurthy B; Singh A; Pasupathy K; Dong Y; O'Horo JC; Wilson WR; Mitchell O; Kingsley TC
    BMJ; 2021 May; 373():n1087. PubMed ID: 33980718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.